Developer docs
API playgroundTry for free, no card

Search company profiles

Wisner Baum

Full company profile

uuid0009k2f

Namestring
Wisner Baum
Legal namestring
Wisner Baum LLP
Websiteurl
wisnerbaum.com
Company typeenum
Private
Founded yearint
1985
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mass tort litigation, personal injury law, product liability cases, toxic tort lawsuits, plaintiff-side representation
Industry3 codes
1Litigation & Dispute Resolution
CodeBPAHAAABPrimaryYes
2Personal Injury & Insurance Defense
CodeBPAHAAAMPrimaryNo
3Litigation Support & Expert Witness Services
CodeBPAHALAGPrimaryNo
NAICS code2 codes
  • Offices of Lawyers541110
  • Legal Services5411
SIC code1 code
  • Services-Legal Services8111
Product category
Plaintiff Mass Tort and Personal Injury Legal Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Legal Services - Contingency Fees
TypeProfessional Services
Description

The firm operates on a contingency fee basis, collecting fees only when cases are won or settled. This aligns the firm's interests with clients and is typical for personal injury and mass tort litigation.

wisnerbaum.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Others, Infrastructure
Pricing details1 tier
1Contingency fee arrangement - no upfront costs to clients
ModelOtherBilling cadenceMulti-year contract
Notes

Clients are not charged fees unless the firm successfully recovers compensation on their behalf through settlement or verdict.

wisnerbaum.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Wisner Baum provides plaintiff-side legal representation in mass tort, personal injury, and consumer protection litigation matters, including pharmaceutical drug lawsuits, toxic tort cases, defective medical device claims, California wildfire litigation, aviation wrongful death actions, and consumer class actions. The firm operates on a contingency fee basis — clients pay no upfront fees and the firm is compensated only through successful verdicts or settlements. Its portfolio spans more than a dozen distinct practice areas, anchored by the Roundup/glyphosate litigation track record.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over $4 billion in verdicts and settlements recovered for clients
+2 more records
Product overview1 text field

Wisner Baum is a plaintiff-side mass tort and personal injury law firm offering legal representation services across diverse practice areas. The firm operates as a unified legal services practice rather than a technology product company, providing specialized litigation services in pharmaceutical drug liability, toxic torts, defective medical devices, consumer class actions, and wildfire victims' rights. Their portfolio spans over a dozen distinct practice areas including Roundup/glyphosate litigation (with a notable $2.055 billion verdict), GLP-1 drug lawsuits (Ozempic, Wegovy, Mounjaro), Zantac/ranitidine claims, toxic baby food class actions, atrazine and paraquat herbicide litigation, and California wildfire litigation. The firm has recovered over $4 billion for clients and represents over 20,000 families.

Product and service16 records
1Roundup/Glyphosate Litigation
CategoryMass Tort / Toxic Tort Litigation
Description

Legal representation for individuals alleging non-Hodgkin lymphoma or other cancers from exposure to Roundup herbicide containing glyphosate. Represented by Wisner Baum across trial and settlement phases; practice includes individual cases and the Roundup class action.

2GLP-1 Drug Litigation (Ozempic, Wegovy, Mounjaro, Rybelsus)
CategoryMass Tort / Prescription Drug Litigation
Description

Legal representation for individuals filing claims alleging adverse effects from GLP-1 receptor agonist medications used for diabetes and obesity, including Ozempic, Wegovy, Mounjaro, and Rybelsus.

3Toxic Baby Food Litigation
CategoryMass Tort / Consumer Class Action
Description

Legal representation for families alleging autism and ADHD diagnoses in children caused by exposure to toxic heavy metals in commercial baby food products.

4Zantac (Ranitidine) Cancer Litigation
CategoryMass Tort / Prescription Drug Litigation
Description

Legal representation for individuals alleging cancer caused by NDMA contamination in Zantac (ranitidine) heartburn and ulcer medications.

5Suboxone Dental Injury Litigation
CategoryMass Tort / Prescription Drug Litigation
Description

Legal representation for individuals alleging dental injuries caused by Suboxone, a medication used in opioid use disorder treatment.

6Atrazine Herbicide Litigation
CategoryMass Tort / Toxic Tort Litigation
Description

Legal representation for individuals alleging non-Hodgkin lymphoma and other health effects from exposure to the atrazine herbicide.

7Paraquat Parkinson's Disease Litigation
CategoryMass Tort / Toxic Tort Litigation
Description

Legal representation for individuals alleging Parkinson's disease caused by occupational or environmental exposure to the paraquat herbicide.

8Chlorpyrifos Pesticide Litigation
CategoryMass Tort / Toxic Tort Litigation
Description

Legal representation for individuals alleging Parkinson's disease caused by exposure to the chlorpyrifos pesticide.

9Antipsychotic Drug Litigation (Zyprexa, Risperdal, Invega)
CategoryMass Tort / Prescription Drug Litigation
Description

Legal representation for individuals alleging breast cancer risk or other adverse effects from antipsychotic medications, including Zyprexa, Risperdal, and Invega.

10California Wildfire Litigation
CategoryCatastrophic Personal Injury / Wrongful Death
Description

Legal representation for individuals and families who suffered property loss, injury, or wrongful death in California wildfires, with negligence claims against utility companies including Southern California Edison and PG&E.

11Port Catheter Injury Litigation
CategoryDefective Medical Device Litigation
Description

Legal representation for individuals injured by defective port catheters used in chemotherapy and long-term IV therapy.

12Spinal Cord Stimulator Injury Litigation
CategoryDefective Medical Device Litigation
Description

Legal representation for individuals injured by defective spinal cord stimulator devices used in chronic pain management.

13Dexcom Continuous Glucose Monitor Class Action
CategoryDefective Medical Device Litigation / Consumer Class Action
Description

Class action representation for individuals harmed by Dexcom G6 and G7 continuous glucose monitoring devices manufactured with allegedly unapproved materials that caused speaker malfunctions and device failures.

14Consumer Class Action Services
CategoryConsumer Class Action
Description

Consumer class action representation for groups of individuals harmed by defective products and unlawful corporate practices, including the Actos RICO class action and benzoyl peroxide acne products litigation.

15Aviation Wrongful Death and Injury Representation
CategoryCatastrophic Personal Injury / Wrongful Death - Aviation
Description

Plaintiff-side legal representation for wrongful death and catastrophic injury claims arising from commercial and regional aviation accidents, including the Bering Air Flight 445 litigation.

16Civil Rights / Excessive Force Litigation
CategoryCivil Rights Litigation
Description

Plaintiff-side civil rights litigation seeking accountability for excessive force and other constitutional violations, including individual verdicts against municipal defendants.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierSupportingTypeGTM or Marketing PartnerAnnounced on2025-11-19
Description

JOTO PR Disruptors™ partnered with Wisner Baum LLP to promote its anti-PR strategy and support the firm's legal campaigns for corporate accountability. The partnership focuses on transparency and justice initiatives.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest U.S. plaintiff personal injury firm with national advertising scale. Competes for mass tort plaintiffs and wildfire/civil rights matters, though it operates a much broader volume-driven model than Wisner Baum's boutique trial approach.

TypeDirect peer
Description

New York plaintiff mass tort firm with deep pharmaceutical, medical device, and toxic exposure practices. Direct peer in drug (Zantac, GLP-1) and environmental litigation.

TypeDirect peer
Description

Texas-based plaintiff mass tort firm focused on environmental, pharmaceutical, and product liability litigation. Directly comparable in toxic tort (Roundup, atrazine, paraquat) and consumer class action work.

TypeDirect peer
Description

National plaintiff class action and mass tort firm with product liability and consumer protection focus. Comparable in class action MDL leadership and consumer product cases like baby food and CGM devices.

TypeDirect peer
Description

National plaintiff mass tort and class action firm with strong pharmaceutical and medical device practices. Closely comparable in GLP-1, medical device, and consumer class action work.

TypeDirect peer
Description

Illinois-based plaintiff mass tort firm with national reach in asbestos, pharmaceutical, and Roundup litigation. Competes for bellwether trial slots in the same MDLs Wisner Baum litigates.

TypeDirect peer
Description

Florida-based plaintiff mass tort firm with pharmaceutical, medical device, and consumer class action practices. Direct peer in mass tort trial work.

TypeDirect peer
Description

San Francisco-based plaintiff mass tort and class action firm with parallel product liability, pharmaceutical, and consumer cases. Direct competitor for lead counsel roles in MDLs like Roundup and consumer class actions.

TypeBroad incumbent
Description

Established national firm with significant plaintiff mass tort and class action practice. Overlaps with Wisner Baum in pharmaceutical and consumer class actions, though it also operates a robust defense-side practice.

TypeDirect peer
Description

Plaintiff mass tort firm with parallel pharmaceutical, opioid, and environmental toxic exposure cases. Comparable mid-sized boutique plaintiff practice.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wisner Baum

Plaintiff Mass Tort and Personal Injury Legal Serviceswisnerbaum.com

Wisner Baum firmographics

Firmographics
Name
Wisner Baum
Legal name
Wisner Baum LLP
Website
https://wisnerbaum.com
Company type
Private
Founded year
1985
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Wisner Baum industry classification

Industry
Product category
Plaintiff Mass Tort and Personal Injury Legal Services
NAICS
Offices of Lawyers (541110), Legal Services (5411)
SIC
Services-Legal Services (8111)
akta.pro primary industry
Litigation & Dispute Resolution (BPAHAAAB)
akta.pro secondary industries
Personal Injury & Insurance Defense (BPAHAAAM), Litigation Support & Expert Witness Services (BPAHALAG)

Keywords

  • Mass tort litigation
  • Personal injury law
  • Product liability cases
  • Toxic tort lawsuits
  • Plaintiff-side representation

Where Wisner Baum is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Wisner Baum business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others, Infrastructure

Revenue model

  1. Legal Services - Contingency Fees: The firm operates on a contingency fee basis, collecting fees only when cases are won or settled. This aligns the firm's interests with clients and is typical for personal injury and mass tort litigation.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractContingency fee arrangement - no upfront costs to clients

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Wisner Baum product offering

Product offering

Core offering

Wisner Baum provides plaintiff-side legal representation in mass tort, personal injury, and consumer protection litigation matters, including pharmaceutical drug lawsuits, toxic tort cases, defective medical device claims, California wildfire litigation, aviation wrongful death actions, and consumer class actions. The firm operates on a contingency fee basis — clients pay no upfront fees and the firm is compensated only through successful verdicts or settlements. Its portfolio spans more than a dozen distinct practice areas, anchored by the Roundup/glyphosate litigation track record.

Product overview

Wisner Baum is a plaintiff-side mass tort and personal injury law firm offering legal representation services across diverse practice areas. The firm operates as a unified legal services practice rather than a technology product company, providing specialized litigation services in pharmaceutical drug liability, toxic torts, defective medical devices, consumer class actions, and wildfire victims' rights. Their portfolio spans over a dozen distinct practice areas including Roundup/glyphosate litigation (with a notable $2.055 billion verdict), GLP-1 drug lawsuits (Ozempic, Wegovy, Mounjaro), Zantac/ranitidine claims, toxic baby food class actions, atrazine and paraquat herbicide litigation, and California wildfire litigation. The firm has recovered over $4 billion for clients and represents over 20,000 families.

Differentiator

Problem solved

Functional benefit

Products and services

  • Roundup/Glyphosate Litigation Legal representation for individuals alleging non-Hodgkin lymphoma or other cancers from exposure to Roundup herbicide containing glyphosate. Represented by Wisner Baum across trial and settlement phases; practice includes individual cases and the Roundup class action.
  • GLP-1 Drug Litigation (Ozempic, Wegovy, Mounjaro, Rybelsus) Legal representation for individuals filing claims alleging adverse effects from GLP-1 receptor agonist medications used for diabetes and obesity, including Ozempic, Wegovy, Mounjaro, and Rybelsus.
  • Toxic Baby Food Litigation Legal representation for families alleging autism and ADHD diagnoses in children caused by exposure to toxic heavy metals in commercial baby food products.
  • Zantac (Ranitidine) Cancer Litigation Legal representation for individuals alleging cancer caused by NDMA contamination in Zantac (ranitidine) heartburn and ulcer medications.
  • Suboxone Dental Injury Litigation Legal representation for individuals alleging dental injuries caused by Suboxone, a medication used in opioid use disorder treatment.
  • Atrazine Herbicide Litigation Legal representation for individuals alleging non-Hodgkin lymphoma and other health effects from exposure to the atrazine herbicide.
  • Paraquat Parkinson's Disease Litigation Legal representation for individuals alleging Parkinson's disease caused by occupational or environmental exposure to the paraquat herbicide.
  • Chlorpyrifos Pesticide Litigation Legal representation for individuals alleging Parkinson's disease caused by exposure to the chlorpyrifos pesticide.
  • Antipsychotic Drug Litigation (Zyprexa, Risperdal, Invega) Legal representation for individuals alleging breast cancer risk or other adverse effects from antipsychotic medications, including Zyprexa, Risperdal, and Invega.
  • California Wildfire Litigation Legal representation for individuals and families who suffered property loss, injury, or wrongful death in California wildfires, with negligence claims against utility companies including Southern California Edison and PG&E.
  • Port Catheter Injury Litigation Legal representation for individuals injured by defective port catheters used in chemotherapy and long-term IV therapy.
  • Spinal Cord Stimulator Injury Litigation Legal representation for individuals injured by defective spinal cord stimulator devices used in chronic pain management.
  • Dexcom Continuous Glucose Monitor Class Action Class action representation for individuals harmed by Dexcom G6 and G7 continuous glucose monitoring devices manufactured with allegedly unapproved materials that caused speaker malfunctions and device failures.
  • Consumer Class Action Services Consumer class action representation for groups of individuals harmed by defective products and unlawful corporate practices, including the Actos RICO class action and benzoyl peroxide acne products litigation.
  • Aviation Wrongful Death and Injury Representation Plaintiff-side legal representation for wrongful death and catastrophic injury claims arising from commercial and regional aviation accidents, including the Bering Air Flight 445 litigation.
  • Civil Rights / Excessive Force Litigation Plaintiff-side civil rights litigation seeking accountability for excessive force and other constitutional violations, including individual verdicts against municipal defendants.

Quantifiable outcome

  • Over $4 billion in verdicts and settlements recovered for clients
  • +2 more outcomes

Companies that use Wisner Baum

Customer profile

Named customers3 records

Segments1 record

Ideal customer profiles2 records

Wisner Baum technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Wisner Baum partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • JOTO PR Disruptors™supportingGTM or Marketing Partner · 19 November 2025JOTO PR Disruptors™ partnered with Wisner Baum LLP to promote its anti-PR strategy and support the firm's legal campaigns for corporate accountability. The partnership focuses on transparency and justice initiatives.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Wisner Baum competitors and assessment

Company assessment

Broad incumbents

  • Morgan & Morgan: Largest U.S. plaintiff personal injury firm with national advertising scale. Competes for mass tort plaintiffs and wildfire/civil rights matters, though it operates a much broader volume-driven model than Wisner Baum's boutique trial approach.
  • Robins Kaplan: Established national firm with significant plaintiff mass tort and class action practice. Overlaps with Wisner Baum in pharmaceutical and consumer class actions, though it also operates a robust defense-side practice.

Direct peers

  • Weitz & Luxenberg: New York plaintiff mass tort firm with deep pharmaceutical, medical device, and toxic exposure practices. Direct peer in drug (Zantac, GLP-1) and environmental litigation.
  • Baron & Budd: Texas-based plaintiff mass tort firm focused on environmental, pharmaceutical, and product liability litigation. Directly comparable in toxic tort (Roundup, atrazine, paraquat) and consumer class action work.
  • Keller Postman: National plaintiff class action and mass tort firm with product liability and consumer protection focus. Comparable in class action MDL leadership and consumer product cases like baby food and CGM devices.
  • Seeger Weiss: National plaintiff mass tort and class action firm with strong pharmaceutical and medical device practices. Closely comparable in GLP-1, medical device, and consumer class action work.
  • Simmons Hanly Conroy: Illinois-based plaintiff mass tort firm with national reach in asbestos, pharmaceutical, and Roundup litigation. Competes for bellwether trial slots in the same MDLs Wisner Baum litigates.
  • Levin Papantonio Rafferty: Florida-based plaintiff mass tort firm with pharmaceutical, medical device, and consumer class action practices. Direct peer in mass tort trial work.
  • Lieff Cabraser Heimann & Bernstein: San Francisco-based plaintiff mass tort and class action firm with parallel product liability, pharmaceutical, and consumer cases. Direct competitor for lead counsel roles in MDLs like Roundup and consumer class actions.
  • Napoli Shkolnik: Plaintiff mass tort firm with parallel pharmaceutical, opioid, and environmental toxic exposure cases. Comparable mid-sized boutique plaintiff practice.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Wisner Baum social profiles

Digital presence

Wisner Baum financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wisner Baum leadership team

Management profile

Number of profiles

Profiles16 records

Wisner Baum funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wisner Baum M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wisner Baum

What does Wisner Baum do?

Wisner Baum provides plaintiff-side legal representation in mass tort, personal injury, and consumer protection litigation matters, including pharmaceutical drug lawsuits, toxic tort cases, defective medical device claims, California wildfire litigation, aviation wrongful death actions, and consumer class actions. The firm operates on a contingency fee basis — clients pay no upfront fees and the firm is compensated only through successful verdicts or settlements. Its portfolio spans more than a dozen distinct practice areas, anchored by the Roundup/glyphosate litigation track record.

Is Wisner Baum a public or private company?

Wisner Baum is a private company. It is classified as management employee owned and is currently operating.

When was Wisner Baum founded?

Wisner Baum was founded in 1985. It employs 51 to 100 people.

Where is Wisner Baum based?

Wisner Baum is headquartered in Los Angeles, United States, in the North America region.

How does Wisner Baum make money?

One revenue line is on record: legal Services - Contingency Fees.

Who are Wisner Baum's main competitors?

Broad incumbents on record are Morgan & Morgan and Robins Kaplan. Direct peers are Weitz & Luxenberg, Baron & Budd, Keller Postman, Seeger Weiss, Simmons Hanly Conroy, Levin Papantonio Rafferty, Lieff Cabraser Heimann & Bernstein and Napoli Shkolnik.

Does Wisner Baum have an API?

No public API is recorded for Wisner Baum.

What industry is Wisner Baum in?

Wisner Baum's product category is Plaintiff Mass Tort and Personal Injury Legal Services. Its primary akta.pro industry code is BPAHAAAB, Litigation & Dispute Resolution, with a secondary code of BPAHAAAM, Personal Injury & Insurance Defense. Its NAICS code is 541110 and its SIC code is 8111.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The IndependentRFK Jr quietly changed ethics pledge sparking new scrutiny over financial dealingsHealth Secretary Robert F. Kennedy Jr. altered an ethics pledge, assigning legal case interests to his former employer Wisner Baum instead of his son. Senate Democrats, including Elizabeth Warren, sent a letter demanding details, citing potential conflicts of interest.PressdemocratDemocrats press RFK Jr. on an ethics agreement change involving law firm feesDemocrats are pressing Health Secretary Robert F. Kennedy Jr. over an undisclosed change to his ethics agreement, which they say transferred his stake in a vaccine litigation to his former law firm Wisner Baum. The senators' letter questions his credibility and potential conflict of interest, while HHS says he complied with his ethics agreement.San Diego Union-TribuneDemocrats press RFK Jr. on an ethics agreement change involving law firm feesDemocrats are pressing Health Secretary Robert F. Kennedy Jr. over an undisclosed change to his ethics agreement, which they say transferred his stake in a vaccine litigation to his former law firm Wisner Baum. The senators' letter questions his credibility and potential conflict of interest, while HHS says Kennedy complied with his ethics agreement.The Mercury NewsDemocrats press RFK Jr. on an ethics agreement change involving law firm feesDemocrats are pressing Health Secretary Robert F. Kennedy Jr. over an undisclosed change to his ethics agreement, which they say transferred his stake in Gardasil litigation fees to his former law firm Wisner Baum. The senators' letter questions his credibility and potential conflict of interest, noting he had pledged to transfer the stake to his son.Ground NewsDemocrats press RFK Jr. on an ethics agreement change involving law firm feesDemocratic senators sent a letter to Health Secretary Robert Kennedy questioning an undisclosed change to his ethics agreement involving his financial interests in law firm Wisner Baum. They cited concerns that any future payment could create an ongoing conflict of interest, and Kennedy has not responded.Atlanta Journal-ConstitutionDemocrats press RFK Jr. on an ethics agreement change involving law firm feesDemocrats are pressing Health Secretary Robert F. Kennedy Jr. over an undisclosed change to his ethics agreement, which they say calls into question his credibility. They claim he transferred his stake to his former employer, Wisner Baum, contradicting his sworn commitments.YahooDemocratic senators accuse Kennedy of not adhering to ethics agreement in vaccine lawsuitDemocratic senators questioned whether HHS Secretary Robert F. Kennedy concealed an agreement to collect money from a Merck vaccine settlement, despite pledging to divest. The Merck settlement paid $50 million, and Wisner Baum said neither Kennedy nor his son would receive it, contradicting Kennedy's earlier statements. Kennedy's son is an associate at Wisner Baum.YahooDemocrats press RFK Jr. on an ethics agreement change involving law firm feesDemocrats are pressing Health Secretary Robert F. Kennedy Jr. over an undisclosed change to his ethics agreement, which they say transferred his stake in a law firm to his former employer, Wisner Baum. The senators' letter questions his credibility and potential conflict of interest, noting he initially pledged to transfer fees to his son.NPREthics watchdogs await RFK Jr.'s financial reportHealth Secretary RFK Jr.'s annual financial disclosure is late, with ethics watchdogs awaiting it. He said referral fees from a Merck HPV vaccine lawsuit went to his law firm Wisner Baum, not his family, though the settlement amount was not disclosed. The filing is due in the next few days.PR NewswireWisner Baum Named to Leadership in Federal Spinal Cord Stimulator LitigationWisner Baum attorneys Behram V. Parekh and Hannah Quicksell were appointed to leadership roles in the Boston Scientific spinal cord stimulator multidistrict litigation. Parekh is one of three Co-Lead Counsel, and Quicksell joins the Leadership Development Committee. The firm also seeks to consolidate cases against Abbott and Nevro, with a hearing scheduled for September 24.